You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

《新股消息》传加科思药业(01167.HK)以上限14元定价

阿思达克 12-15 12:39
据路透旗下IFR引述接近交易的消息人士指,加科思药业(01167.HK)计划以每股14元定价,为招股价范围12元至14元的上限,集资约13.5亿元。加科思预计於12月21日上市,由高盛及中金担任联席保荐人。